Related references
Note: Only part of the references are listed.Meta-analysis of neutropenia or leukopenia as a prognostic factor in patients with malignant disease undergoing chemotherapy
Kohei Shitara et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Is chemotherapy-induced neutropenia a prognostic factor in patients with ovarian cancer?
Jae-Joon Kim et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2010)
Chronotherapy and the molecular clock: Clinical implications in oncology
Pasquale F. Innominato et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Neutropenia as a prognostic factor in advanced gastric cancer patients undergoing second-line chemotherapy with weekly paclitaxel
K. Shitara et al.
ANNALS OF ONCOLOGY (2010)
The Role of Clock Genes in Pharmacology
Georgios K. Paschos et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Circadian Timing in Cancer Treatments
Francis Levi et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
The Mammalian Circadian Timing System: Organization and Coordination of Central and Peripheral Clocks
Charna Dibner et al.
ANNUAL REVIEW OF PHYSIOLOGY (2010)
ETHICS AND METHODS FOR BIOLOGICAL RHYTHM RESEARCH ON ANIMALS AND HUMAN BEINGS
Francesco Portaluppi et al.
CHRONOBIOLOGY INTERNATIONAL (2010)
Dissecting Variability in Responses to Cancer Chemotherapy Through Systems Pharmacology
R. Yang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Circadian cell cycle variations of erythro- and myelopoiesis in humans
Jenny Foss Abrahamsen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer
D. Cunningham et al.
ANNALS OF ONCOLOGY (2009)
Circadian Rhythm in Rest and Activity: A Biological Correlate of Quality of Life and a Predictor of Survival in Patients with Metastatic Colorectal Cancer
Pasquale F. Innominato et al.
CANCER RESEARCH (2009)
Neutropaenia as a prognostic factor in metastatic colorectal cancer patients undergoing chemotherapy with first-line FOLFOX
Kohei Shitara et al.
EUROPEAN JOURNAL OF CANCER (2009)
Myelotoxicity of Preoperative Chemoradiotherapy Is a Significant Determinant of Poor Prognosis in Patients With T4 Esophageal Cancer
Norikatsu Miyoshi et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
Metabolism and cancer: the circadian clock connection
Saurabh Sahar et al.
NATURE REVIEWS CANCER (2009)
Individual fluorouracil dose adjustment based on pharmacokinetic follow-up compared with conventional dosage: Results of a multicenter randomized trial of patients with metastatic colorectal cancer
Erick Gamelin et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: A prospective clinical trial by the German 5-FU toxicity study group
Matthias Schwab et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Five-Year Data and Prognostic Factor Analysis of Oxaliplatin and Irinotecan Combinations for Advanced Colorectal Cancer: N9741
Hanna K. Sanoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The genetics of mammalian circadian order and disorder: implications for physiology and disease
Joseph S. Takahashi et al.
NATURE REVIEWS GENETICS (2008)
Mammalian circadian signaling networks and therapeutic targets
Andrew C. Liu et al.
NATURE CHEMICAL BIOLOGY (2007)
Implications of circadian clocks for the rhythmic delivery of cancer therapeutics
Francis Levi et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Predictive value of chemotherapy-induced neutropenia for the efficacy of oral fluoropyrimidine S-I in advanced gastric carcinoma
T. Yamanaka et al.
BRITISH JOURNAL OF CANCER (2007)
Circadian rhythms: Mechanisms and therapeutic implications
Francis Levi et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2007)
Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer:: The European Organisation for Research and Treatment of Cancer Chronotherapy group
Sylvie Giacchetti et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: A Multicenter study of the Gruppo Oncologico Dell'Italia Meridionale
G Colucci et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Effects of light and food schedules on liver and tumor molecular clocks in mice
E Filipski et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Differences in toxicity between men and women treated with 5-fluorouracil therapy for colorectal carcinoma
K Chansky et al.
CANCER (2005)
Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer
T Rich et al.
CLINICAL CANCER RESEARCH (2005)
Effects of chronic jet lag on tumor progression in mice
E Filipski et al.
CANCER RESEARCH (2004)
Dosing strategies for anticancer drugs: the good, the bad and body-surface area
A Felici et al.
EUROPEAN JOURNAL OF CANCER (2002)
Circadian optimisation of irinotecan and oxaliplatin efficacy in mice with Glasgow osteosarcoma
TG Granda et al.
BRITISH JOURNAL OF CANCER (2002)
Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer:: results of a multivariate analysis of 3825 patients
CH Köhne et al.
ANNALS OF ONCOLOGY (2002)
Rhythms in human bone marrow and blood cells
R Smaaland et al.
CHRONOBIOLOGY INTERNATIONAL (2002)
Tumor-based rhythms of anticancer efficacy in experimental models
TG Granda et al.
CHRONOBIOLOGY INTERNATIONAL (2002)
Rhythms in human gastrointestinal mucosa and skin
GA Bjarnason et al.
CHRONOBIOLOGY INTERNATIONAL (2002)
Circadian expression of clock genes in human oral mucosa and skin : Association with specific cell-cycle phases
GA Bjarnason et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7)
F Maindrault-Goebel et al.
EUROPEAN JOURNAL OF CANCER (2001)
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
A de Gramont et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Diurnal cortisol rhythm as a predictor of breast cancer survival
SE Sephton et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer
S Giacchetti et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
